| Literature DB >> 36135553 |
Zupeng Gao1, Raufa Batool1, Weifeng Xie1,2, Xiaodan Huang1,2, Zhenying Wang1.
Abstract
Pests are inevitably exposed to sublethal and lethal doses in the agroecosystem following the application of pesticides indispensable to protect food sources. The effect of spinetoram on amino-acid metabolism of fall armyworm, Spodoptera frugiperda (J.E. Smith), was investigated, at the dose of LC10 and LC90, by transcriptome and LC-MS/MS analysis. Using statistics-based analysis of both POS and NEG mode, a total of 715,501 metabolites in S. frugiperda were significantly changed after spinetoram treatment. The enhancement of glucose metabolism provides energy support for detoxification in larvae. The decrease in valine and isoleucine is associated with an increase in leucine, without maintaining the conservation of citric acid in the larvae. The down-regulation of phenylalanine may retard the tricarboxylic acid cycle to produce GTP. The abundance of lysine was decreased in response to spinetoram exposure, which damages the nervous system of the larvae. The abundance of arginine increases and causes non-functional contraction of the insect's muscles, causing the larva to expend excess energy. Tryptophan provides an important substrate for eliminating ROS. The changes in glutamic acid, aspartic acid, and lysine cause damage to the nerve centers of the larvae. The results of transcriptome and LC-MS/MS analysis revealed the effects of pesticide exposure on amino-acid metabolism of S. frugiperda successfully and provide a new overview of the response of insect physio-biochemistry against pesticides.Entities:
Keywords: amino acid; metabolism; physio-biochemistry; spinetoram; spodoptera frugiperda
Year: 2022 PMID: 36135553 PMCID: PMC9504701 DOI: 10.3390/insects13090852
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 3.139
Summary of transcriptome sequencing data.
| Sample | Clean Reads | Clean Bases | Mapped Read | Guanine-Cytosine Content (%) | Q20(%) | Q30(%) | |
|---|---|---|---|---|---|---|---|
| CK | Control-1 | 24,804,561 | 7,399,530,118 | 36,072,981 (72.71%) | 48.04 | 98.29 | 94.93 |
| Control-2 | 25,406,000 | 7,581,035,800 | 367,63,311 (72.35%) | 48.00 | 97.86 | 94.93 | |
| Control-3 | 20,529,036 | 6,132,802,190 | 29,967,481 (72.99%) | 47.78 | 97.94 | 93.77 | |
| Control-4 | 21,455,769 | 6,405,367,636 | 31,161,221 (72.62%) | 49.17 | 97.71 | 93.29 | |
| LC10 | Spin10-1 | 24,388,290 | 7,285,860,770 | 34,931,682 (71.62%) | 48.22 | 97.95 | 93.82 |
| Spin10-2 | 23,612,040 | 7,059,990,216 | 33,693,849 (71.35%) | 47.86 | 97.71 | 93.32 | |
| Spin10-3 | 23,612,040 | 6,567,603,744 | 31,630,174 (71.99%) | 47.92 | 97.59 | 93.03 | |
| Spin10-4 | 21,780,281 | 6,504,361,012 | 31,270,395 (71.79%) | 48.20 | 97.78 | 93.44 | |
| LC90 | Spin90-1 | 20,923,896 | 6,261,061,732 | 29,946,614 (71.56%) | 47.73 | 97.63 | 93.03 |
| Spin90-2 | 20,796,109 | 6,220,125,194 | 29,921,237 (71.94%) | 47.40 | 97.64 | 93.10 | |
| Spin90-3 | 25,473,623 | 7,599,203,900 | 36,194,890 (71.04%) | 48.25 | 97.83 | 93.53 | |
| Spin90-4 | 27,731,793 | 8,274,619,114 | 39,174,512 (70.63%) | 48.49 | 97.86 | 93.65 |
Figure 1Transcriptome response of S. frugiperda to spinetoram stress. (A) Pearson’s correlation coefficient analysis. (B,C) Derived from volcano plots of transcriptome in Control vs. LC10 and Control vs. LC90, respectively. KEGG pathways in Control vs. LC10 (D), Control vs. LC90 (E), and LC10 vs. LC90 (F). Metabolic profiles of S. frugiperda in response to spinetoram treatment.
Changes of key genes in S. frugiperda by exposure to LC10 and LC90 concentration of the spinetoram compared to the control group (t-test p < 0.05).
| Unigene ID | Gene Annotation | Type of Regulation | |
|---|---|---|---|
| LC10 Group | LC90 Group | ||
| LOC118266960 | 5-hydroxytryptamine receptor | Up | Up |
| LOC118275809 | 5-hydroxytryptamine receptor 1A | - | Up |
| LOC118262451 | acetylcholinesterase | Up | Up |
| LOC118268389 | acetylcholine receptor subunit alpha | Up | Up |
| LOC118275478 | cholinesterase 2 | - | Up |
| LOC118276148 | esterase B1 | - | Up |
| LOC118276231 | juvenile hormone esterase-like | Down | Down |
| LOC118274652 | glucose dehydrogenase | Up | Up |
| LOC118277268 | glucose-1-phosphatase-like | Up | - |
| LOC118277428 | facilitated trehalose transporter Tret | Up | - |
| LOC118277941 | UTP--glucose-1-phosphate uridylyl transferase | Up | - |
| LOC118269585 | glucose transporter type | Up | Up |
| LOC118280239 | dehydrogenase | Up | Up |
| LOC118280972 | UDP-N-acetyl hexosamine pyrophosphorylase-1 | Up | Up |
| LOC118262085 | acetyl-coenzyme A synthetase | - | Down |
| LOC118266444 | 3-ketoacyl-CoA thiolase | Up | - |
| LOC118280410 | acetyl-CoA carboxylase | Up | Up |
| LOC118267788 | connectin | - | Up |
| LOC118266022 | hydroxymethylglutaryl-CoA synthase | - | Down |
| LOC118281649 | 2-oxoglutarate dehydrogenase | - | Up |
| LOC118278502 | ATP-citrate synthase | Up | - |
| LOC118262464 | isocitrate dehydrogenase [NADP] cytoplasmic | Down | Down |
| LOC118266957 | 4-aminobutyrate aminotransferase | Up | Up |
| LOC118272711 | gamma-aminobutyric acid receptor | Up | Up |
| LOC118262156 | glutamate synthase [NADH] | Up | Up |
| LOC118265687 | glutamyl-tRNA (Gln) amidotransferase subunit B | Up | Up |
| LOC118282360 | asparagine synthetase | Down | Down |
| LOC118268389 | acetylcholine receptor subunit alpha | Up | Up |
| LOC118276145 | muscarinic acetylcholine receptor DM1 | Up | Up |
| LOC118282418 | catalase | Down | Down |
| LOC118266989 | superoxide dismutase | Up | Up |
| LOC118269785 | glutathione S-transferase 1 | Down | Down |
| LOC118271638 | glutathione S-transferase 2 | Down | Down |
| LOC118268807 | glutathione hydrolase 1 proenzyme | Up | Up |
| LOC118280652 | carbonyl reductase [NADPH] 3 | Down | Down |
| LOC118266432 | leukotriene A-4 hydrolase | - | Down |
| LOC118269281 | glutaryl-CoA dehydrogenase | Up | Up |
| LOC118273421 | tyrosine aminotransferase | Up | Up |
| LOC118267609 | dopamine N-acetyltransferase | - | Up |
| LOC118277744 | venom carboxylesterase-6 | Up | Up |
| LOC118281189 | cytochrome P450 307a | Down | Down |
| LOC118274175 | cytochrome P450 6B6 | Down | Down |
| LOC118270797 | cytochrome P450 4C1 | Up | Up |
| LOC118270458 | cytochrome P450 4c21 | Up | Up |
| LOC118272240 | cytochrome P450 4c3 | Up | Up |
| LOC118282431 | cytochrome P450 4d2 | Up | Up |
| LOC118266763 | cytochrome P450 6a2 | Up | Up |
| LOC118273800 | cytochrome P450 6B2 | Up | Up |
| LOC118262785 | cytochrome P450 6B5 | Up | Up |
| LOC118264635 | cytochrome P450 9e2 | Up | Up |
| LOC118271250 | cytochrome P450 301a1 | Up | Up |
| LOC118279412 | UDP-glucuronosyltransferase 2B15 | Up | Up |
| LOC118269333 | UDP-glucuronosyltransferase 2B19 | Up | Up |
| LOC118279357 | UDP-glucuronosyltransferase 2B7 | Up | Up |
Figure 2Metabolic profile in S. frugiperda exposed to sublethal and lethal dose of the spinetoram. (A) Principal component analysis (PCA) model of Spin10, Spin 90, and Control at pro-model, (B) partial least squares-discriminant analysis (PLS-DA) model of Spin10, Spin90, and Control at neg-model.
Figure 3Analysis of differentially expressed (DE) metabolites in S. frugiperda to spinetoram stress. (A) Numbers of metabolites that were up-regulated (red) and down-regulated (green) in spinetoram-stressed fall armyworm larvae. (B–E) Heatmaps of DE metabolites in fall armyworm at pos-mode (B,C) and neg-mode (D,E) after spinetoram stress. Each column represents one sample, and each row represents one DE metabolite. Red color represents the relative level of the up-regulated metabolites, and green color represents down-regulation Metabolic pathway analysis.
Figure 4Summary of pathway analysis. (A) Pathway analysis of LC10 and control groups at neg-mode. (B) Pathway analysis of LC90 and control groups at neg-mode. (C) Pathway analysis of LC10 and control groups at pos-mode. (D) Pathway analysis of LC90 and control groups at pos-mode. (E) Pathway analysis of LC10 and LC90 groups at neg-mode. (F) Pathway analysis of LC10 and LC90 groups at pos-mode. The color and size of the shapes represent the regulated degree of the pathways by the treatment of doses of the spinetoram; larger, red shapes indicate a greater effect on the pathway.
Changes of key metabolites in S. frugiperda by exposure to LC10 and LC90 dose of the spinetoram compared to the control group (t-test p < 0.05).
| Metablite ID | Metabolite Name | LC10 Group | LC90 Group |
|---|---|---|---|
| neg_127 | D-Glucose 6-phosphate | Up | Up |
| neg_149 | Dehydroascorbic acid | - | Up |
| neg_39 | Tyrosine | - | Down |
| neg_399 | Arginine | Up | Up |
| neg_412 | Leucine | Up | Up |
| neg_58 | NADP+ | - | Up |
| neg_76 | Glutamate | Up | Up |
| pos_136 | L-Valine | Down | Down |
| pos_194 | Aspartic acid | Up | Up |
| pos_198 | Tryptophan | - | Up |
| pos_379 | Arachidyl carnitine | - | Up |
| pos_517 | delta. -Tocopherol | - | Up |
| pos_613 | DL-Phenylalanine | - | Down |
| pos_732 | Glutethimide | - | Down |
| pos_752 | Acetylcholine | - | Down |
| pos_766 | Allysine | Down | Down |
| pos_79 | NAD | - | UP |
| pos_904 | Epigallocatechin gallate | - | Down |
| pos_99 | L-Isoleucine | - | Down |